1-3 of 3
Christopher B Ryder
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

XPO1 Drives Resistance to Eprenetapopt and Azacitidine and Can Be Targeted in TP53-Mutated Myeloid Malignancies

Available to Purchase
Traci L Kruer, Ariel Quintana-Gonzalez, Hannah L Newman, Meghan C. Ferrall-Fairbanks, Ling Zhang, Amy F McLemore, Surendra Neupane, Qin Yang, Nana Adjoa Ben-Crentsil, Maria E. Balasis, Christopher T Letson, Rami S Komrokji, Sana Chaudhry, Tulasigeri M Totiger, Joshua A Traina, Maria E Figueroa, Christopher B Ryder, Thomas Cluzeau, Justin Taylor, David A Sallman, Eric Padron
Journal: Blood
Blood blood.2025028803.
https://doi.org/10.1182/blood.2025028803
Published: 2025
Includes: Supplemental data
Journal Articles

A Longitudinal Evaluation of Cytopenia Severity in Patients with Clonal Cytopenia of Undetermined Significance (CCUS) and Correlation with the Presence of Sub-Clinical Dysplasia

Free
Michael Daunov, Howard Meyerson, Kwadwo Asare Oduro, Jr., Christopher B Ryder, Navid Sadri, Jennifer Yoest, Shufen Cao, Pingfu Fu, Rose Beck, Benjamin Tomlinson
Journal: Blood
Blood (2021) 138 (Supplement 1): 3705.
https://doi.org/10.1182/blood-2021-153506
Published: 2021
Journal Articles

Direct-Acting Small Molecule Activators of PP2A (SMAPs) in Myeloid Malignancies: Understanding Mechanisms of Cytotoxicity to Inform Rational Combinatorial Therapeutic Strategies

Free
Christopher B Ryder, Goutham Narla, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2517.
https://doi.org/10.1182/blood.V130.Suppl_1.2517.2517
Published: 2017